Chronic Antibody-Mediated Rejection Latest Advances

Tocilizumab for the treatment of chronic antibody mediated rejection in kidney transplant recipients.

Journal: Clinical transplantation

Published: April 12, 2022

Long-term liver allograft fibrosis: A review with emphasis on idiopathic post-transplant hepatitis and chronic antibody mediated rejection.

Journal: World journal of hepatology

Published: November 09, 2021

Immunoenzymatic Staining of Caveolin-1 in Formalin-Fixed Renal Graft Showing Chronic Antibody Mediated Rejection.

Journal: Transplantation proceedings

Published: December 21, 2018

THE USE OF BORTEZOMIB FOR THE TREATMENT OF CHRONIC ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION

Journal: Nihon Hinyokika Gakkai zasshi. The japanese journal of urology

Published: January 01, 2018

Treatment of chronic antibody mediated rejection with intravenous immunoglobulins and rituximab: A multicenter, prospective, randomized, double-blind clinical trial.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: April 13, 2017

Differential modulation of donor-specific antibodies after B-cell depleting therapies to cure chronic antibody mediated rejection.

Journal: Transplantation

Published: July 17, 2014

The effect of combination therapy with rituximab and intravenous immunoglobulin on the progression of chronic antibody mediated rejection in renal transplant recipients.

Journal: Journal of immunology research

Published: June 15, 2013

Chronic antibody mediated rejection of renal allografts: pathological, serological and immunologic features in nonhuman primates.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: June 20, 2006